What this trial studies
The aim of this clinical trial is to evaluate the effects of different forms of physical exercise in women experiencing menopausal symptoms. Specifically, the project investigates the effects of: (1) strength training on women's perceived menopausal symptoms; (2) dance-based exercise on women's perceived menopausal symptoms; and (3) adherence to structured, digital home-based exercise programs. The following research questions will be addressed within the framework of the project: Does regular strength training reduce women's perceived menopausal symptoms? To what extent does strength training influence menopausal symptoms and sleep quality in women?
Conditions in scope
- Menopause Syndrome
- Sleep Disturbance
Interventions
- Strength training (Other) — The strength training intervention consists of an 8-week program performed 3 times per week, with sessions lasting \~30 minutes. Designed by a licensed physiotherapist, the program targets major muscle groups and includes a warm-up followed by structured exercises. Training uses…
- Dance-based training (Other) — Participants in the dance-based intervention will exercise three times per week at moderate intensity, following a structured 30-minute program performed individually at home via pre-recorded sessions. After each session, participants will complete a training diary and rate perceived exertion using…
Who can join
Women only · Ages 45 Years to 55 Years
Inclusion criteria
- Biological female sex
- Age 45-55 years
- Experiencing menopausal symptoms, defined as irregular or altered menstruation plus at least one of the following:
- Hot flashes or sweating
- Sleep problems
- Mood swings or depression
- Dry mucous membranes
- Recurrent urinary tract infections or overactive bladder
Exclusion criteria
- Have taken medication or natural remedies for menopausal symptoms in the past 2 months
- Menopause due to illness or surgical intervention
- Medical conditions that contraindicate participation in the exercise intervention
- Engaged in physical activity for ≥150 minutes per week, including ≥ 75 minutes at high intensity
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Kalmar | Sofia Ryman Augustsson | Recruiting |
Status & timeline
- Overall status: Recruiting
- Study type: Interventional
- Phase: N/A
- Start date: 2025-11-01
- Primary completion: 2026-05
- Last update posted: 2026-01-20
- First posted: 2026-01-20
Sponsor & contact
Lead sponsor: Linnaeus University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Menopause Rating Scale (MRS) (2 times: 1) Baseline: Day 1 and 2) Post intervention: week 8)
The Menopause Rating Scale (MRS) consists of 11 items grouped into three dimensions: * Somatic Symptoms: Hot flashes, joint pain, and related physical complaints. * Psychological Symptoms: Depressive mood, irritability, anxiety, and similar issues. * Urogenital Symptoms: Bladder problems, vaginal dryness, and related concerns. Each item is rated on a 5-point Likert scale from 0 (not present) to 4 (very…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07351006 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.